The abortion pill mifepristone has long been at the center of heated political discussions. But a new review suggests that ...

The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...

Courts are increasingly confronting AI-generated and AI-manipulated evidence land on their dockets. But with innovation comes ...

One noted exception to the finding that agency leaders largely adhered to the evidence-based recommendations of scientists happened during the first Trump term, while covid restrictions were in place, ...

By making sweeping changes to the nation's childhood vaccine schedule, America's top health leaders are recklessly maximizing ...

M.S. in Biodiversity Data Analytics Program Director Viorel Popescu examines why biodiversity commitments are running into a ...

Three key themes emerged across the mifepristone documents: consistent safety findings, lack of ideological bias in staff ...

A study of more than 5,000 pages of agency documents on mifepristone over 12 years found that agency leaders almost always ...

Barnes & Thornburg attorneys Lauren Baker and John W. Cox examine the practical uses, benefits, and challenges of using ...

Invoking the Catholic principle of subsidiarity, Millea said 'let those closest to the children who are getting the ...

Explore the impact of drug discovery automation in 2026, addressing complexity and improving decision-making across ...

An analysis of internal Food and Drug Administration documents by researchers at the Johns Hopkins Bloomberg School of Public Health finds that the agency generally followed cautious and ...